section_path: Early career/Our Ohio Renewal
section_name: Our Ohio Renewal
paragraph_text: Our Ohio Renewal
  
  In December 2016, Vance said he planned to move to Ohio and would consider starting a nonprofit or running for office. In Ohio, he started Our Ohio Renewal, a 501(c)(4) advocacy organization focused on education, addiction, and other "social ills" he had mentioned in his memoir. According to a 2017 archived capture of the nonprofit's website, the advisory board members were Keith Humphreys, Jamil Jivani, Yuval Levin, and Sally Satel. According to a 2020 capture of the website, those four remained in those positions throughout the organization's existence. Our Ohio Renewal closed by 2021 with sparse achievements. According to Jivani, the organization's director of law and policy, its work was derailed by Jivani's cancer diagnosis. It raised around $221,000 in 2017 (including $80,000 from Vance himself) and spent most of its revenue on overhead costs and travel. In subsequent years, it raised less than $50,000.
  
  During Vance's 2022 U.S. Senate campaign, Tim Ryan, the Democratic nominee, said the charity was a front for Vance's political ambitions. Ryan pointed to reports that the organization paid a Vance political adviser and conducted public opinion polling, while its efforts to address addiction failed. Vance denied the characterization. Our Ohio Renewal's tax filings showed that in its first year, it spent more (over $63,000) on "management services" provided by its executive director Jai Chabria, who also served as Vance's top political adviser, than it did on programs to fight opioid abuse. In 2017, Vance formed a similarly named 501(c)(3) organization, Our Ohio Renewal Foundation, which raised around $69,000 from 2017 to 2023. As of September 2024, the foundation had not spent any funds since 2019.
  
  According to the Associated Press (AP) and a 2019 ProPublica investigation, the charity's biggest accomplishment, sending psychiatrist Sally Satel to Ohio's Appalachian region for a yearlong residency in 2018, was "tainted" by the ties among Satel, her employer, American Enterprise Institute (AEI), and Purdue Pharma, in the form of knowledge exchange between Satel and Purdue and financial support from Purdue to AEI. Satel denied having any relationship with Purdue or any knowledge of its donations to AEI.